Cecilie_Arcurs/E+ via Getty Images A few months ago, we wrote an article about Hims & Hers Health (NYSE:HIMS) titled: "Hims & Hers: 3 Reasons To Buy This Potential Growth Stock". In that article, we made the case that the stock was incredibly undervalued when compared to the company's growth opportunity and TAM over the long term. Since then, the stock has rallied more than 50%, as we were lucky enough to catch nearly the exact bottom with our article: Seeking Alpha However, while HIMS's market opportun ...